The Indian pharmaceutical sector is poised to make a significant impact on the international arena at the 2025 Clinical Pharmacy Congress London (CPCL), the most prominent gathering of clinical pharmacy experts in Europe.
This event offers an exceptional platform to display India’s progress in the pharmaceutical realm, healthcare innovations, and clinical pharmacy services to an influential audience comprising decision-makers and industry luminaries.
Slated for 2025 in London, the CPCL will welcome over 3,400 clinical pharmacy professionals, including key financial authorities, influential decision-makers, and leaders from the UK and other regions. This congress serves as a global center for knowledge sharing and professional networking, uniting top healthcare minds to discuss innovations, build collaborations, and propel clinical pharmacy forward.
The congress will prominently feature India’s increasing role in the world pharmaceutical market, with several leading companies and organizations in attendance. Notably, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) will lead the charge to showcase the nation’s pharmaceutical expertise.
Commenting on the event’s significance, K Raja Bhanu, director general of Pharmexcil, remarked, “The Clinical Pharmacy Congress London provides India a distinct opportunity to assert its leadership in pharmaceuticals and clinical pharmacy, allowing seamless engagement with a highly focused audience such as decision-makers, budget authority, and healthcare professionals to reveal India’s potential as a global healthcare collaborator.”
For additional information on India’s participation and opportunities at CPCL 2025, contact Pharmexcil at [email protected].
Pharmexcil plans to establish a dedicated exhibition booth to spotlight Indian pharmaceutical industry innovations, showcasing advanced drug products, healthcare innovation, and clinical services.
“Our presence at CPCL highlights India’s resolve to advance global healthcare through breakthroughs, partnerships, and providing high-quality solutions. This event is vital to fortifying ties with international stakeholders,” added Raja Bhanu.
CPCL 2025 will showcase a diverse array of exhibitors, featuring pharmaceutical firms presenting clinical-oriented medications and therapies, medical device innovators with cutting-edge equipment for pharmacy and healthcare settings, along with healthcare tech providers demonstrating tools like pharmacy management software and electronic health records.
Additional highlights include clinical research organizations (CROs) exhibiting their significance in trials and pharmaceutical studies, educational bodies promoting training and scholarly growth in clinical pharmacy, tech and software firms introducing innovative solutions to enhance pharmacy efficacy and patient care, consulting agencies offering expertise on regulatory compliance, quality assurance, and optimizing pharmacy practices, as well as pharmacy associations representing professional entities and projects aimed at elevating pharmacy practices worldwide.
Exhibitors are presented with numerous options to maximize their visibility, including Shell Scheme Stands: Ready-to-use spaces with walls, carpeting, and fascia name boards. Space-Only Stands: Fully customizable areas for businesses to create distinctive setups. Stand dimensions vary from 6 sqm (£5,594 + VAT) to more extensive tailored options, ensuring flexibility for exhibitors of diverse scales.
CPCL’s hallmark is the chance for direct, one-on-one engagement with a meticulously targeted audience of clinical pharmacy specialists. These personal interactions facilitate the building of significant relationships, increased brand exposure, and sustained business growth.
“India’s involvement at CPCL 2025 signifies the nation’s growing role as a trustworthy partner in global healthcare. By engaging with the UK’s healthcare leaders and decision-makers, the Indian pharmaceutical industry aims to expand its export capabilities, establish collaborations, and participate in advancing global healthcare,” declared Raja Bhanu.